More than one third of patients with early prostate cancer receive "mismatched" treatments, and men who receive mismatched treatments have worse outcomes. Medscape Medical News
The use of radioiodine remnant ablation in most patients with low-risk papillary thyroid cancer is overtreatment, says a prominent expert in the field. Medscape Medical News
In randomized controlled trials, patients treated with infliximab for moderately to severely active ulcerative colitis were less likely to undergo colectomy through 54 weeks vs those receiving placebo. Medscape Medical News